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Population-based cancer registries form a valuable resource for
public health and research, by providing information on the
surveillance of cancer incidence and survival. The utility of such
registries depends heavily on the completeness with which
patients eligible for registration are ascertained, but registries
rarely report their completeness because it is difficult to measure.
Current methods of estimating completeness have several defects.
The most widely used approach employs indirect indices of the
completeness of registration, such as the ratio of cancer incidence
to mortality in a given period, or the percentage of ‘death certifi-
cate only’ (DCO) registrations (Parkin et al, 1994). The values of
such indices can be compared with those obtained in other
registries. However, they give only a broad indicator of quality, not
an accurate estimate of completeness, and interpretation depends
on assumptions about survival rates and the level of completeness
in the other registries. Although the ratio of DCO to total registra-
tions is widely used as an ‘important check on the completeness of
registration’ (Parkin and Muir, 1993), Brenner (1995a) has shown
that it is unreliable even as an indirect guide.
A second approach involves re-ascertainment of cases. The
registry’s staff search the medical records of all patients in a suit-
able sample of hospitals or other data sources for all registrable
cancers. The proportion of eligible patients who are already regis-
tered is then a direct and quantitative estimate of completeness.
However, this approach is too expensive and time-consuming for
routine use, and only assesses the completeness of patients
attending the data sources sampled. Results have rarely been
published (Heiberger et al, 1983; Mattsson et al, 1985; Galceran et
al, 1995).
A third approach involves obtaining an independent sample of
cancer patients resident in the registry’s territory, e.g. from cohort
studies that do not rely on the same flagging system as the registry
(Hunt and Coleman, 1987; Storm, 1988; Villard-Mackintosh et al,
1988; Hawkins and Swerdlow, 1992), or a series of clinical cases
(Haddow, 1968; Larsson, 1971; Freedman, 1978; Nwene and
Smith, 1982; Draper et al, 1989 Swerdlow et al, 1993;
Warnakulasuriya et al, 1994). The proportion of eligible patients in
this external sample who were also registered by the cancer
registry provides an estimate of completeness. Some authors have
used capture–recapture analyses to estimate completeness from
two or more sources (Robles et al, 1988; Brenner, 1995b). This
opportunistic approach is convenient and labour-saving, but relies
heavily on the independence of the two data sources and this may
be difficult to check. Moreover, such methods are unable to esti-
mate the number of cases not routinely notified to the registry by
any of the sources, and lack the statistical power to detect incom-
pleteness at an early stage (Schouten et al, 1994).
The method proposed here addresses the defects of existing
methods in several ways. It is based on the logical flow of data in
the registration system, and on the time distribution of various
probabilities inherent in this flow. It is thus in principle adaptable
to cancer registries with different patterns of registration. It does
not require re-abstraction of data, and can be executed rapidly and
inexpensively, thus providing routine surveillance of completeness
by variables such as tumour site, age, sex and geographic area.
METHODS
The aim of cancer registries is to register cancers at, or soon after,
diagnosis. However, some cases are missed. UK cancer registries
obtain patient information from hospitals, pathology laboratories,
GP practices, general cancer registries in other regions where
members of their populations may have been treated and from
specialist cancer registries restricted to a particular age group 
or tumour site. Additionally, copies of all death certificates
mentioning malignant disease are sent by the Office for National
Statistics (ONS) to the cancer registry.
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DOI: 10.1054/ bjoc.1999.1048, available online at http://www.idealibrary.com on The following methodology relies on the assumptions that death
certificates are received for all patients dying with malignant
disease mentioned on the death certificate, and that patients are not
registered from sources other than death certificates after death. A
search of the Thames Cancer Registry’s database found no patients
who were known from independent sources to have died for whom
a death certificate had not been received from ONS. Moreover,
only a fraction of a per cent of patients dying without cancer being
mentioned on the death certificate (who would not have been
registered initially from the death certificate) were registered after
death.
Since cancer patients who subsequently die with cancer
mentioned on the death certificate are (in the UK) routinely noti-
fied to the relevant registry, fatal cases are highly likely to be
registered. The patients who remain unregistered at a given time
after diagnosis of cancer are of two types. Firstly, patients who are
alive and still unregistered (i.e. ‘missing’ from the register). Or
patients who have died without being registered during life, and
remain unregistered because the death certificate did not mention
cancer. There is little chance of such patients ever being registered,
and such cases may be described as ‘lost’ to the system. This
process is illustrated in Figure 1.
We define three time-dependent probabilities, as follows:
s(ti) is the probability that a cancer patient is still surviving
at time ti after diagnosis
m(ti) is the probability that the death certificate of a patient
who dies in the time interval (ti, ti+1) after diagnosis includes a
mention of cancer
u(ti) is the probability that a patient surviving until time ti
after diagnosis is still unregistered.
We can then derive the proportions of ‘missing’ (M) and ‘lost’
(L) patients as follows:
1. Missing Proportion ‘missing’ at time ti after diagnosis is
given by
M(ti) = prob (surviving and still being unregistered at time ti)
= s(ti) · u(ti)
2. Lost From the survival distribution, the probability that a
death occurs during the time interval (ti, ti+1) is
s(ti) – s(ti+1)
Then prob (death occurs in interval (ti, ti+1) and cancer not
mentioned)
= [s(ti) – s(ti+1)] · [1 – m(ti)]
Since any patient who has died without being registered had
clearly not been registered whilst still alive, it follows that
prob (death occurs in interval (ti, ti+1) and patient not previously
registered and cancer not mentioned on death certificate)
= [s(ti) – s(ti+1)] · [1 – m(ti)] · u(ti)
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Figure 1 Relationships between the various possible categories of registered and unregistered cancer patients at time t after diagnosisAt time T after diagnosis, a cancer patient who is dead yet
remains unregistered could have died at any time ti (0<ti<T). Thus
the proportion ‘lost’ at time T is given by
L(T) = prob (dead by time T and unregistered and cancer not
mentioned)
= Sn
i=0 {[s(ti) – s(ti+1)] · [1 – m(ti)] · u(ti)}
with tn ≤ T < tn+1 and where to (=0) is the time of diagnosis.
Completeness at time T after diagnosis, C(T), can now be found
by subtracting from unity the proportions of patients who are
‘missing’ or ‘lost’, to give
C(T) = 1 – M(T) – L(T)
= 1 – s(tn) · u (tn) – Sn
i=0{ [s(ti) – s(ti+1)] · [1 – m(ti)] · u(ti)}
also with tn ≤ T < tn+1.
Thus, if reasonable estimates of the three time-dependent proba-
bilities implicit in Figure 1 can be obtained, then completeness can
be readily estimated. s(t) can be obtained from the distribution of
survival times for registered patients, m(t) can be estimated from
the death certificates of a sample of registered patients who have
died, and u(t) from the distribution of the interval between diag-
nosis and registration.
Probability of survival, s(t)
The survival distribution can be estimated using the actuarial
method (Cutler and Ederer, 1958; Esteve et al, 1994). Convention
amongst cancer registries is to calculate survival for all cancers
diagnosed in a given period among residents of its territory.
Patients registered solely from a death certificate (DCO cases) are
usually excluded because their date of diagnosis is unknown.
However, this practice can lead to bias. Berrino et al (1995) have
shown that patients dying with cancer mentioned on the death
certificate have poorer survival than patients dying of other causes,
and that the percentage reduction in estimated survival resulting
from the inclusion of DCO cases is generally of the same order as
the proportion of such cases in the series under study. If possible,
DCOs should be included as outlined below.
It is important to estimate the survival distribution for patients
rather than tumours. Some 5–10% of cancer patients will eventu-
ally develop more than one primary, but the criteria for registering
a second primary vary between cancer registries (Parkin et al,
1994). It is in any case intuitively sensible to include each patient
only once, using the date of registration of the first tumour.
It is not clear how DCOs should be included in estimates of
survival, since both their date of diagnosis and their duration of
survival are unknown. To address this problem a working assump-
tion was made that, for any given period, the unknown number of
cancer patients whose true date of diagnosis lies within that period,
but who will eventually be registered as DCOs, is the same as the
number of DCOs recorded as dying in that period. If the survival
distribution of cases diagnosed in 1987 were required, for
example, the estimate would be based on non-DCO cases diag-
nosed in 1987 and DCO cases dying in 1987.
DCOs are distinguished from other death-certificate-initiated
(DCI) cases only in that the registry has not succeeded in tracing
the patient’s medical record to obtain the date of diagnosis. It
therefore seems reasonable to apply the survival distribution of
successfully traced-back DCI patients to those for whom trace-
back was unsuccessful, i.e. the DCO cases.
The survival times for DCO cases can therefore be approximated
by the survival distribution of those DCI patients whose details were
successfully traced back from the death certificate and who were
diagnosed in the required period, specific for age at death, sex,
tumour type and geographic area.
It may be possible to refine the method further by categorizing
dead cases by place of death (e.g. hospital, hospice, home, etc.).
However, this idea has not been pursued in the current study.
Probability that cancer is mentioned on the death
certificate, m(t)
This can be estimated from cancer registrations for patients who
are now dead. The same sample of patients used to estimate the
survival distribution can also be used for this purpose. The numer-
ator is the number of deaths in the given interval since diagnosis
for which the death certificate includes a mention of cancer, while
the denominator is the total number of deaths in the same interval.
The simplest approach is to use patients diagnosed in a given
calendar period who are now dead. This will tend to overestimate
the true probability of cancer being mentioned on the death certifi-
cate, since all patients who die of their cancers will be registered,
whilst some patients who die of other causes will not.
Probability of failure of registration before death, u(t)
The cancer registry receives copies of all death certificates
mentioning cancer for deaths in its territory, irrespective of
whether the patient has already been registered. Crucially, this
source of information depends on civil death registration, and is
completely independent from the sources of routine cancer regis-
tration. These certificates enable u(t) to be calculated for cancer
deaths occurring in a given period.
The periods from diagnosis to registration and from diagnosis to
death are calculated (with estimates for DCOs being made as
described above). The probability of a patient not being registered
before death can then be estimated with the same approach as for
survival, but treating registration before death as the ‘event’, and
censoring at death.
This was refined by censoring at 1 year before death, because
the probability of registration among those who die of cancer
increases during the year or so before death. The death certificates
of patients sampled to estimate u(t) contain a mention of cancer,
whereas u(t) is to be applied to survivors and to patients whose
death certificate does not mention cancer. Censoring 1 year before
death removes most of this excess probability, and the resultant
distribution is more suitable for non-cancer deaths.
RESULTS
The survival distribution s(t) was based on 56 992 cases ‘diag-
nosed’ in 1987, including 14 409 DCO cases dying in 1987, but
excluding non-melanoma skin cancers and patients resident
outside the registry’s territory. Five years after diagnosis, almost
80% of these patients had died (Figure 2).
m(t) was calculated from the records of patients diagnosed in
1987 who had died by the end of 1993. The data comprised 42 971
patients (including 14 409 DCOs) whose death certificate did
mention cancer and 2620 patients whose death certificate did not.
In the period immediately after diagnosis, as expected, most death
certificates mentioned cancer, but this proportion fell to approxi-
mately 80% by 5 years after diagnosis.
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calculated from all cancer deaths recorded at the registry during
1991. As before, patients with non-melanoma skin cancer and
patients resident outside the registry’s territory were excluded. The
45 384 cancer deaths comprised 9744 (21.5%) registrations made
before death, 28 327 (62.4%) patients whose registration was
made from the medical records after receipt of a death certificate
and 7313 (16.1%) DCOs. In the first 6 months after diagnosis,very
few surviving cases were registered (Figure 3). Most registrations
of survivors occurred between 6 months and 2 years after diag-
nosis, and the probability that a surviving case remained unregis-
tered gradually fell to 23% at 5 years after diagnosis.
Since this study was performed, improvements to the computer-
ized matching of records together with active tracing of
unmatched deaths have reduced the DCO rate at Thames Cancer
Registry to 10.5% at the end of 1998.
Figure 4 shows the derived distribution of completeness C(T)
with time for Thames Cancer Registry. The area above the bold
curve represents the patients who remain unregistered at any given
time. The thinner line divides these unregistered patients into those
who are still alive (the ‘missing’) and those who have died without
cancer being mentioned on the death certificate, and who are
unlikely ever to be registered (the ‘lost’). The results indicate that
Thames Cancer Registry attains 92.1% completeness 5 years after
diagnosis for all cancers.
The same method was used to calculate completeness by age
and cancer site. The samples used to calculate the distributions
s(t), m(t) and u(t) were restricted to the age group or cancer site of
interest. Otherwise, the calculations were performed exactly as
above.
For estimation of completeness by age at diagnosis, the selec-
tion of DCOs causes difficulty, because the age at diagnosis is
unknown. However, since age at death is available, we can apply
the survival distribution of those patients whose date of diagnosis
and duration of survival are known as a result of trace-back from
the death certificate to each DCO in the same category of age at
death. (We used the conventional 5-year age groups.) The esti-
mated age at diagnosis for each DCO can then be found by
subtraction. Those patients registered as a DCO whose estimated
age at diagnosis falls outside the specified range are then ignored.
The rest of the calculations are as before, within each age group at
diagnosis.
Figure 5A shows the pattern of completeness by time since
diagnosis for selected cancer sites. Registration appears most
complete for lung cancer, the most lethal of those shown.
Melanoma of the skin is the least complete of the selected sites.
Whilst breast cancer and melanoma have similar survival distribu-
tions s(t), u(t) is higher for melanoma, resulting in lower complete-
ness.
Figure 5B shows the results for different age groups. In general,
completeness is higher at older ages due to the fact that survival
rates are lower in older patients, and death certificates can be used
to improve case ascertainment. The only exception appears to be
that childhood cancers (0–14 years) are more completely regis-
tered than those in young adults. This is due to greater efficiency
of the routine registration procedures for the youngest patients.
Completeness of registration for other combinations of factors
can be obtained by a suitable choice of the samples for estimating
the three probability distributions.
DISCUSSION
One advantage of this method over others in common use is that it
shows how the completeness of registration of cancer patients
diagnosed in a given period increases with time since diagnosis.
Another advantage is the inclusion of an estimate of the
percentage of cancer patients who are likely never to be registered
(the ‘lost’ group). Further, the interpretation of this estimate of
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Figure 2 The estimated survival distribution s(t) for all cancer patients
(excluding non-melanoma skin cancer) diagnosed in 1987
Figure 4 The completeness of cancer registration C(T) at Thames Cancer
Registry for all cancers diagnosed in 1987 (excluding non-melanoma skin
cancer) by time since diagnosis
Figure 3 The probability that a surviving cancer patient remains
unregistered by time since diagnosis, u(t)completeness does not depend on assumptions about the efficiency
of other cancer registries (as with indirect indices) or other data
sources (independent case ascertainment).
Three crucial requirements must be met for the method to be
applicable. First, the date when each cancer is first registered must
be systematically recorded. This date should not be changed
subsequently, regardless of any further patient information that
may be acquired. Although most of the UK cancer registries do
record this date, it would be desirable to include it in any future
national minimum data set. If dates of registration have only been
recorded for the past T years, then u(t) and hence completeness can
only be calculated up to T years after diagnosis. Ideally, the date of
registration should be available for 3 or more years before the
method is implemented, in order to ensure that the probability
distribution of registration before death is estimated for a reason-
able period.
Secondly, it is also essential that copies of all death certificates
mentioning cancer should be received. This may be a problem for
small regional registries in countries where there is no national
follow-up system or matching with a national death index.
Thirdly, knowledge of whether each case is DCI is also
required, in order to estimate the survival times for DCO cases as
described above.
The method should improve comparability between cancer
registries, since estimates of completeness could now refer to stan-
dard intervals such as 1, 2 or 5 years after diagnosis, and should
enable more systematic exploration of variation in completeness
by factors such as age, sex and type of tumour. However, the esti-
mate of completeness should not be over-interpreted if the
numbers used in the samples to calculate the underlying distribu-
tions are small. The effects of smaller numbers can be seen in the
‘lumpiness’ of some of the estimates presented in Figure 5.
Treatment of cancer patients is continually improving, leading
to increased survival and an ever greater proportion of patients
being ‘cured’ to eventually die of other causes, with no mention of
cancer on the death certificate. Unless registration procedures
improve, this will result in decreased levels of completeness.
Incompleteness results in biased estimates of cancer incidence,
prevalence and survival. The routine publication of completeness
figures for standard intervals would aid the interpretation of such
measures.
ACKNOWLEDGEMENTS
This work was carried out at Thames Cancer Registry with
funding from South West Thames Regional Health Authority’s
Locally Organised Research Fund. The authors would like to thank
Stephen Darlington for help with computing and graphics, and
Bendix Carstensen, Roger Black and Eric Holowaty for their
helpful comments and suggestions.
REFERENCES
Berrino F, Estève J and Coleman MP (1995) Basic issues in estimating and
comparing the survival of cancer patients. In: Survival of Cancer Patients in
Europe: the EUROCARE Study, Berrino F, Sant M, Verdecchia A, Capocaccia
R, Hakulinen T and Estève J (eds), pp. 1–14. IARC Scientific Publication No.
132. IARC: Lyon
Brenner H (1995a) Limitations of the death certificate only index as a measure of
incompleteness of cancer registration. Br J Cancer 72: 506–510
Brenner H (1995b) Use and limitations of the capture–recapture method in disease
monitoring with two dependent sources. Epidemiology 6: 42–48
Cutler SJ and Ederer F (1958) Maximum utilisation of the life table method in
analysing survival. J Chron Dis 8: 699–712
Draper GJ, Bower BD, Darby SC and Doll R (1989) Completeness of registration of
childhood leukaemia near nuclear installations and elsewhere in the Oxford
region. Br Med J 299: 952–952
Estève J, Benhamou E and Raymond L (1994) Statistical Methods in Cancer
Research, Volume IV. Descriptive Epidemiology. IARC Scientific Publication
No. 128. IARC: Lyon
Freedman LS (1978) Variations in the level of reporting by hospitals to a regional
cancer registry. Br J Cancer 37: 861–865
Completeness of cancer registration 1115
British Journal of Cancer (2000) 82(5), 1111–1116 © 2000 Cancer Research Campaign
C
o
m
p
l
e
t
e
n
e
s
s
 
(
%
)
A
B
C
o
m
p
l
e
t
e
n
e
s
s
 
(
%
)
100
80
60
40
20
0
100
80
60
40
20
0
0 1 2 3 4 5
Time since diagnosis (years)
0 1 2 3 4 5
Time since diagnosis (years)
Lung
Colon
Breast
Cervix
Melanoma
85+
75–84
65–74
45–64
15–44
00–14
Figure 5 The completeness of cancer registration by time since diagnosis:
(A) by cancer site; (B) by age at diagnosisGalceran J, Porta M, Martin M, Mariné E and Borràs J (1995) Completeness of Cancer
Registration in Tarragona, 1980–1989: an Independent Case Ascertainment
Study, pp. 99. International Association of Cancer Registries: Rio de Janeiro
Haddow AJ (1968) The coverage achieved by the cancer registration scheme in the
Western Hospital Region of Scotland in 1965. Health Bull (Edinburgh) 26: 10–12
Hawkins MM and Swerdlow AJ (1992) Completeness of cancer and death follow-up
obtained through the National Health Service Central Register for England and
Wales. Br J Cancer 66: 408–413
Heiberger RM, Miller CL, Feigl P, Lane WW and Glaefke G (1983) A novel method
of assessing completeness of tumor registration. Cancer 51: 2362–2366
Hunt K and Coleman MP (1987) The completeness of cancer registration in follow-
up studies – a cautionary note. Br J Cancer 56: 357–359
Larsson S (1971) Completeness and reliability of lung cancer registration in the
Swedish Cancer Registry. Acta Pathol Microbiol Immunol Scand 79: 389–398
Mattsson B, Rutqvist LE and Wallgren A (1985) Under-notification of diagnosed
cancer cases to the Stockholm cancer registry. Int J Epidemiol 14: 64–69
Nwene UP and Smith A (1982) Assessing completeness of cancer registration in the
north-western region of England by a method of independent comparison. Br J
Cancer 46: 635–639
Parkin DM, Chen VW, Ferlay J, Galceran J, Storm HH and Whelan SL (1994)
Comparability and Quality Control in Cancer Registration. IARC Technical
Report No. 19. IARC: Lyon
Parkin DM and Muir CS (1993) Comparability and quality of data. In: Cancer
Incidence in Five Continents, Volume VI, Parkin DM, Muir CS, Whelan SL,
Gao Y-T, Ferlay J and Powell J (eds). IARC Scientific Publication No. 120.
IARC: Lyon
Robles SC, Marrett LD, Clarke EA and Risch HA (1988) An application of
capture–recapture methods to the estimation of completeness of cancer
registration. J Clin Epidemiol 41: 495–501
Schouten LJ, Straatman H, Kiemeney LALM, Gimbrère CHF and Verbeek ALM
(1994) The capture–recapture method for estimation of cancer registry
completeness: a useful tool? Int J Epidemiol 23: 1111–1116
Storm HH (1988) Completeness of cancer registration in Denmark 1943–1966 and
efficacy of record linkage procedures. Int J Epidemiol 17: 44–49
Swerdlow AJ, Douglas AJ, Vaughan Hudson G and Vaughan Hudson B (1993)
Completeness of cancer registration in England and Wales: an assessment
based on 2145 patients with Hodgkin’s disease independently registered by
the British National Lymphoma Investigation. Br J Cancer 67: 326–329
Villard-Mackintosh L, Coleman MP and Vessey MP (1988) The completeness of
cancer registration in England: an assessment from the Oxford-FPA
contraceptive study. Br J Cancer 58: 507–511
Warnakulasuriya KAAS, Acworth P, Bell CMJ and Johnson NW (1994)
Incompleteness of oral cancer registration in south-east England, 1971–87. Br J
Cancer 70: 736–738
1116 J Bullard et al
British Journal of Cancer (2000) 82(5), 1111–1116 © 2000 Cancer Research Campaign